STOCK TITAN
  1. Home
  2. Sec-filings
  3. SHPH
  4. [Form 4] Shuttle Pharmaceuticals Holdings, Inc. Insider Trading Activity

Shuttle Pharmaceuticals (SHPH): Steven Richards Receives 29,240 RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Steven M. Richards, a director of Shuttle Pharmaceuticals Holdings (SHPH), was granted 29,240 Restricted Stock Units (RSUs) on 08/08/2025, as reported on a Form 4 signed 08/12/2025. The filing states each RSU represents the contingent right to receive one share of common stock at no cash price.

One-third of the RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028, meaning the award converts into a total of 29,240 shares if all vest according to the stated schedule. The Form 4 lists the ownership form as direct and shows the grant was reported under a non-cash equity award.

Positive

  • 29,240 RSUs granted to a director, aligning executive interests with shareholder outcomes through equity compensation
  • Clear vesting schedule provided: one‑third vests on each of 08/08/2026, 08/08/2027 and 08/08/2028, giving transparent timing for potential share issuance

Negative

  • Potential future issuance of up to 29,240 common shares upon vesting (reported as direct ownership) which could increase share count
  • No grant value disclosed in the Form 4, so monetary magnitude relative to company size is not specified in the filing

Insights

TL;DR: Routine time‑based equity grant to a director, disclosed via Form 4; vesting over three years.

The Form 4 documents a direct award of 29,240 RSUs to director Steven M. Richards dated 08/08/2025 and filed/signed 08/12/2025. The filing explicitly states each RSU converts to one share and that vesting occurs one‑third annually on 08/08/2026, 08/08/2027 and 08/08/2028. This is a standard director equity compensation disclosure and does not, by itself, indicate unusual governance actions or related‑party transactions beyond routine disclosure requirements.

TL;DR: Time‑based RSU award disclosed; details indicate standard vesting and direct beneficial ownership.

The filing shows the award has $0 price and is structured as Restricted Stock Units with a clear vesting schedule (one‑third each year through 2028). The Form 4 lists the position as Director and reports direct beneficial ownership. These specifics provide clarity on timing of potential share issuance but contain no additional metrics such as grant value or share count relative to outstanding shares.

Insider Richards Steven M
Role Director
Type Security Shares Price Value
Grant/Award Restricted Stock Unit 29,240 $0.00 --
Holdings After Transaction: Restricted Stock Unit — 29,240 shares (Direct)
Footnotes (1)
  1. Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock. One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Richards Steven M
(Last) (First) (Middle)
C/O SHUTTLE PHARMACEUTICALS HOLDINGS
401 PROFESSIONAL DRIVE, SUITE 260
(Street)
GAITHERSBURG MD 20879
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Shuttle Pharmaceuticals Holdings, Inc. [ SHPH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 08/08/2025 A 29,240 (2) (2) Common Stock 29,240 $0 29,240 D
Explanation of Responses:
1. Each Restricted Stock Unit ("RSU"s) represents the contingent right to receive one share of common stock.
2. One-third of these RSUs will vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.
/s/ Steven M Richards 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Shuttle Pharmaceuticals (SHPH) report on the Form 4?

Director Steven M. Richards was granted 29,240 Restricted Stock Units (RSUs) on 08/08/2025, reported on a Form 4 signed 08/12/2025.

How do the RSUs granted to Steven M. Richards vest?

The filing states one‑third of the RSUs vest on each of 08/08/2026, 08/08/2027 and 08/08/2028.

How many shares will the RSUs convert into?

Each RSU represents the right to receive one share of common stock, so the award would convert into 29,240 shares if fully vested.

Was there a cash price for the RSUs?

The Form 4 indicates a $0 price for the RSUs; they are non‑cash equity awards.

What is the reported ownership form for the grant?

The RSUs are reported as direct beneficial ownership in the Form 4.